SCHEMBL12345142

SCHEMBL12345142

c1ccc(-c2cncc(-c3ccc4ccc5c(-c6cncc(-c7ccccc7)c6)ccc6ccc3c4c65)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 6/20 0.46
▸ CYP11B2 P19099 5/20 0.46
▸ MKNK1 Q9BUB5 1/20 0.42
▸ MKNK2 Q9HBH9 1/20 0.42
▸ CHRNA7 P36544 1/20 0.41
▸ ATM Q13315 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ SMO Q99835 1/20 0.38
▸ TNF P01375 1/20 0.38
▸ MET P08581 1/20 0.37
▸ FDPS P14324 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CYP17A1 P05093 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ KDR P35968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14849198 0.86 CYP11B1 (0.43) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL29512050 0.86 CYP1A2 (0.44) CYP11B1CYP11B2TNFCYP17A1CYP3A4
SCHEMBL16335156 0.86 CYP1A2 (0.44) CYP11B1CYP11B2TNFCYP17A1CYP3A4
SCHEMBL15446977 0.85 CYP11B1 (0.43) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL13682513 0.85 CYP1A2 (0.41) CYP11B1CYP11B2CYP19A1TNFCYP17A1
SCHEMBL13682531 0.85 CYP1A2 (0.41) CYP11B1CYP11B2MKNK1MKNK2CYP19A1
SCHEMBL25761294 0.83 CYP1A2 (0.39) ATMCYP19A1CYP3A4
SCHEMBL19825219 0.83 MAP3K8 (0.42) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL18174839 0.80 CYP11B1 (0.45) CYP11B1CYP11B2MKNK1MKNK2CHRNA7
SCHEMBL3809322 0.79 ALDH1A1 (0.44) TNFCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2500343-B1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO (CN) 2018-01-31 — — EP disclosed
US-9412951-B2 Organic materials and organic electroluminescent apparatuses using the same BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2016-08-09 — — US disclosed
US-9412951-B2 Organic materials and organic electroluminescent apparatuses using the same BEIJING VISIONOX TECHNOLOGY CO., LTD. (CN) 2016-08-09 — — US disclosed
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO., LTD (CN) 2013-04-11 — — US disclosed
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME BEIJING VISIONOX TECHNOLOGY CO., LTD (CN) 2013-04-11 — — US disclosed
EP-2500343-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME Beijing Visionox Technology Co., Ltd. (CN) 2012-09-19 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130087771-A1 ORGANIC MATERIALS AND ORGANIC ELECTROLUMINESCENT APPARATUSES USING THE SAME OR10J3, ORC3, OR51E2 CYP11B1 832/4885CYP11B2 624/4885MKNK1 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback